Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol (Q52538489)

2 May 2018

title

Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol (English)

1 reference

2 May 2018

author name string

Lin G

series ordinal

1

1 reference

2 May 2018

Oram JF

series ordinal

2

1 reference

2 May 2018

publication date

1 April 2000

1 reference

2 May 2018

published in

Atherosclerosis

1 reference

2 May 2018

volume

149

1 reference

2 May 2018

issue

2

1 reference

2 May 2018

page(s)

359-370

1 reference

2 May 2018

Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes

cites work

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Mechanisms and consequences of cellular cholesterol exchange and transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Scavenger Receptor Class B Type I as a Mediator of Cellular Cholesterol Efflux to Lipoproteins and Phospholipid Acceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Apolipoprotein-mediated cellular cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Role of apolipoproteins A-I, A-II and C-I in cholesterol efflux from endothelial and smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Binding of apolipoprotein A-I and apolipoprotein A-IV to cultured bovine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

High-density lipoprotein and low-density lipoprotein-mediated signal transduction in cultured human skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

HDL3Stimulates Multiple Signaling Pathways in Human Skin Fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Homozygous Tangier disease and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Isolation and characterization of apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

A receptor-mediated pathway for cholesterol homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Presence and Formation of ‘Free Apolipoprotein A-I–Like’ Particles in Human Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

Lipid Composition of HDL Subfractions in Dog Plasma and Lymph

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00503-1

10.1016/S0021-9150(99)00503-1

7 January 2021

Identifiers

DOI

1 reference

2 May 2018

1 reference

2 May 2018